Table 1.
Patient no. | Age at biopsy/sex |
median age with [IQR] in females |
**BLK SNP rs2736340 (C/T) |
SLE nephritis | positive cells/0.01 mm² | ||
---|---|---|---|---|---|---|---|
CD20 | CD43 | CD20/CD43 | |||||
1 | 42/F | non-risk | Class III | 25.1 | 7.9 | 4.3 | |
2 | 30/F | *40.83 | non-risk | Class IV(G) | 3.2 | 1.1 | 0.7 |
3 | 35/F | [33.8 – 45.3], | non-risk | Class IV(S) | 2.8 | 22.3 | 4.3 |
#4 | 41/F | n=6 | non-risk | Class IV(G) | 0.1 | 1.5 | 0.2 |
5 | 55/F | non-risk | Class IV(G) | 0.0 | 3.8 | 1.6 | |
#6 | 42/F | non-risk | Class III | 0.1 | 2.6 | 1.7 | |
7 | 21/F | risk | Class IV(G) | 0.3 | 4.9 | 0.4 | |
8 | 16/F | *25.83 | risk | Class III | 0.0 | 0.6 | 0.0 |
9 | 39/F | [19.8 – 33.0], | risk | Class IV(S) | 0.1 | 2.4 | 0.1 |
10 | 31/F | n=6 | risk | Class IV(G) | 0.1 | 1.3 | 0.0 |
11 | 22/F | risk | Class IV(G) | 0.2 | 1.4 | 0.3 | |
#12 | 26/F | risk | Class III | 0.0 | 1.2 | 4.3 | |
#13 | 59/M | risk | Class IV(G)/V | 0.3 | 10.4 | 1.1 |
p value = 0.020;
non-risk: homozygous for CC; risk: homozygous for TT;
Immunohistofluorescence staining data is shown in Figure 6.